IRF4 and diffuse large B-cell lymphoma: Although coexpression of germinal center markers (CD10 and/or BCL6) and MUM1 is not uncommon in DLBCL, NOS, it is usually a useful clue for screening IRF4 rearrangement to have proper subclassification of the disease.